Elderly individuals in Norway to receive additional COVID-19 vaccine doses amid ongoing health concerns

In the coming weeks, many elderly individuals will be offered another dose of the COVID-19 vaccine. Last year, a significant number of people in high-risk groups opted out of vaccination, despite strong recommendations from health authorities. COVID-19 remains a serious health threat for the elderly and vulnerable populations; the disease claimed the lives of 1,546 Norwegians last year alone. Recent studies indicate that COVID-19 poses a considerably higher risk compared to the flu.

At the same time, the virus is rapidly evolving, with new and more contagious variants emerging. Just last summer, Norway experienced a new surge in cases. The pandemic is far from over, and numerous questions remain unanswered.

An expert panel has been assembled to address inquiries related to COVID-19 and vaccination. The panel will be available to respond to as many questions as possible and may provide answers through previously asked queries. Participants are encouraged to maintain a respectful and focused dialogue.

The experts come from various backgrounds and may hold differing opinions. They include:

– Jörn Klein, a professor of microbiology, epidemiology, and infection control at the University of Southeast Norway, and program manager of Norway’s only master’s program in infection control. – Gunnveig Grødeland, a professor of immunology at the University of Oslo and leader of the Pandemic and One Health Research Center. – Anne Spurkland, an immunologist and professor of anatomy at the University of Oslo, recognized for her outreach efforts regarding the immune system.

This initiative aims to provide crucial information and guidance as society continues to navigate the challenges posed by the pandemic.